Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00314353
What this trial is testing

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Who this might be right for
Colorectal Neoplasms
NSABP Foundation Inc 7
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Not applicableNot Yet RecruitingNCT07306390
What this trial is testing

Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

Who this might be right for
Colon CancerRectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 1,200
Testing effectiveness (Phase 2)Ended earlyNCT01955629
What this trial is testing

Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337551
What this trial is testing

Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive

Who this might be right for
Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment
Guiying Wang 20
Not applicableStudy completedNCT05514561
What this trial is testing

FIT and Fecal Calprotectin in Patients With Chronic Lower GI Symptoms

Who this might be right for
Colorectal CancerColorectal AdenomaColitis
Mahidol University 1,007
Large-scale testing (Phase 3)UnknownNCT01290783
What this trial is testing

Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Alchemia Oncology 390
Testing effectiveness (Phase 2)Study completedNCT01478594
What this trial is testing

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

Who this might be right for
Colorectal Cancer
AVEO Pharmaceuticals, Inc. 265
Not applicableStudy completedNCT01399190
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Study completedNCT00613080
What this trial is testing

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Radiation Therapy Oncology Group 79
Not applicableUnknownNCT03938623
What this trial is testing

Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
Collège de la Médecine Générale, France 274
Early research (Phase 1)Ended earlyNCT04294160
What this trial is testing

Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Novartis Pharmaceuticals 122
Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Early research (Phase 1)Study completedNCT02482441
What this trial is testing

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Who this might be right for
Advanced Relapsed TumorsRefractory Solid Tumors
OncoMed Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT00645710
What this trial is testing

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT03439462
What this trial is testing

Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Aadi Bioscience, Inc. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT05699746
What this trial is testing

CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD

Who this might be right for
Colorectal Cancer
Zhejiang University 38
Next Page